269 related articles for article (PubMed ID: 12564121)
1. Linezolid: implications for neurosurgical infections.
Nguyen CM; Larive LL; Rhoney DH
Neurol Res; 2003 Jan; 25(1):22-6. PubMed ID: 12564121
[TBL] [Abstract][Full Text] [Related]
2. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
Jantausch BA; Deville J; Adler S; Morfin MR; Lopez P; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S164-71. PubMed ID: 14520142
[TBL] [Abstract][Full Text] [Related]
3. Linezolid--a new option for treating gram-positive infections.
Batts DH
Oncology (Williston Park); 2000 Aug; 14(8 Suppl 6):23-9. PubMed ID: 10989821
[TBL] [Abstract][Full Text] [Related]
4. Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2005; 23(9):945-64. PubMed ID: 16153136
[TBL] [Abstract][Full Text] [Related]
5. [Linezolid, an agent from a new class of antibiotics].
Kuijper EJ; Schippers EF; Bernards AT
Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1577-81. PubMed ID: 15382556
[TBL] [Abstract][Full Text] [Related]
6. Linezolid: a new class of antibiotic.
Kupecz D
Nurse Pract; 2000 Nov; 25(11):62-4. PubMed ID: 11107609
[No Abstract] [Full Text] [Related]
7. [Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
Manfredi R
Recenti Prog Med; 2007 Mar; 98(3):143-54. PubMed ID: 17484159
[TBL] [Abstract][Full Text] [Related]
8. Emerging therapies for serious gram-positive bacterial infections: a focus on linezolid.
Plouffe JF
Clin Infect Dis; 2000 Sep; 31 Suppl 4():S144-9. PubMed ID: 11017864
[TBL] [Abstract][Full Text] [Related]
9. Oxazolidinone antibiotics.
Diekema DJ; Jones RN
Lancet; 2001 Dec; 358(9297):1975-82. PubMed ID: 11747939
[TBL] [Abstract][Full Text] [Related]
10. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
Wareham DW; Abbas H; Karcher AM; Das SS
J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
[TBL] [Abstract][Full Text] [Related]
11. Linezolid: the first oxazolidinone antimicrobial.
Lindley DA
Ann Intern Med; 2003 Nov; 139(10):863; author reply 864. PubMed ID: 14623625
[No Abstract] [Full Text] [Related]
12. Clinical trial results with linezolid, an oxazolidinone, in the treatment of soft tissue and postoperative gram-positive infections.
Wilson SE
Surg Infect (Larchmt); 2001; 2(1):25-35. PubMed ID: 12594878
[TBL] [Abstract][Full Text] [Related]
13. Linezolid: the first oxazolidinone antimicrobial.
Moellering RC
Ann Intern Med; 2003 Jan; 138(2):135-42. PubMed ID: 12529096
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo activities of DA-7867, a new oxazolidinone, against aerobic gram-positive bacteria.
Yoon EJ; Jo YW; Choi SH; Lee TH; Rhee JK; Yoo M; Shim MJ; Choi EC
Antimicrob Agents Chemother; 2005 Jun; 49(6):2498-500. PubMed ID: 15917554
[TBL] [Abstract][Full Text] [Related]
15. [New treatment option for gram-positive infections in critically ill patients - overview over linezolid].
Krueger WA; Unertl KE
Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Apr; 37(4):199-204. PubMed ID: 11967745
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of linezolid in liver transplant patients.
Radunz S; Juntermanns B; Kaiser GM; Treckmann J; Mathe Z; Paul A; Saner FH
Transpl Infect Dis; 2011 Aug; 13(4):353-8. PubMed ID: 21355969
[TBL] [Abstract][Full Text] [Related]
17. Linezolid.
Narang M; Gomber S
Indian Pediatr; 2004 Nov; 41(11):1129-32. PubMed ID: 15591662
[TBL] [Abstract][Full Text] [Related]
18. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
Deville JG; Adler S; Azimi PH; Jantausch BA; Morfin MR; Beltran S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S158-63. PubMed ID: 14520141
[TBL] [Abstract][Full Text] [Related]
19. [Linezolid in the treatment of gram positive coccal infections in critical patients].
Alvarez-Lerma F
Rev Esp Quimioter; 2010 Mar; 23(1):1-3. PubMed ID: 20232017
[No Abstract] [Full Text] [Related]
20. Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.
Seedat J; Zick G; Klare I; Konstabel C; Weiler N; Sahly H
Antimicrob Agents Chemother; 2006 Dec; 50(12):4217-9. PubMed ID: 16982791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
